All-trans retinoic acid and interferon-alpha in the treatment of a patient with resistant metastatic osteosarcoma.
about
Drug development against metastasis-related genes and their pathways: A rationale for cancer therapyNuclear receptor agonists as potential differentiation therapy agents for human osteosarcomaNeuronal differentiation of synovial sarcoma and its therapeutic application.Retinoic acid regulates cell cycle progression and cell differentiation in human monocytic THP-1 cellsPharmacokinetics of the time-dependent elimination of all-trans-retinoic acid in rats.Strong inhibition of Ewing tumor xenograft growth by combination of human interferon-alpha or interferon-beta with ifosfamide.
P2860
All-trans retinoic acid and interferon-alpha in the treatment of a patient with resistant metastatic osteosarcoma.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
All-trans retinoic acid and in ...... stant metastatic osteosarcoma.
@en
All-trans retinoic acid and in ...... stant metastatic osteosarcoma.
@nl
type
label
All-trans retinoic acid and in ...... stant metastatic osteosarcoma.
@en
All-trans retinoic acid and in ...... stant metastatic osteosarcoma.
@nl
prefLabel
All-trans retinoic acid and in ...... stant metastatic osteosarcoma.
@en
All-trans retinoic acid and in ...... stant metastatic osteosarcoma.
@nl
P2093
P2860
P1433
P1476
All-trans retinoic acid and in ...... stant metastatic osteosarcoma.
@en
P2093
P2860
P304
P356
10.1002/1097-0142(20001215)89:12<2661::AID-CNCR20>3.0.CO;2-9
P407
P577
2000-12-01T00:00:00Z